![](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA’s Center for ...
For Immediate Release: November 15, 2019 Statement From: Biological products play an increasingly central role in modern medicine, offering treatments for many serious illnesses. Commonly referred to as biologics, these medicines are generally made from …